A study to evaluate the safety of long-term intake of test food in healthy adult subjects - A study to evaluate the safety of long-term intake of test food in healthy adult subjects

Pharma Foods International Co.,Ltd.0 个研究点目标入组 24 人开始时间: 2022年6月9日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Subjects receiving a medical treatment for chronic diseases (dyslipidemia, high blood pressure, diabetes, etc.) (2) Subjects receiving a medical treatment for serious cardio-vascular, hepatic, renal, respiratory, endocrine or metabolic disorders or having a medical history of these disorders (3) Subjects who have the possibility of developing allergic symptoms by the test food (4) Subjects who take Foods for Specified Health Uses or Foods with Function Claims labeled the effects on lipid metabolism (reducing blood LDL cholesterol, triglycerides, body fat, etc.) (5) Subjects who take foods having the effects on lipid metabolism (reducing blood LDL cholesterol, triglycerides, body fat, etc.) (6) Female subjects who are pregnant or lactating, or intending to become pregnant during the study (7) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) (8) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study (9) Subjects deemed unsuitable by the investigator

发起方

Pharma Foods International Co.,Ltd.